These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38534668)

  • 21. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
    Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
    J Glob Antimicrob Resist; 2021 Jun; 25():5-7. PubMed ID: 33662647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus Disease 2019 and Antimicrobial Resistance: Parallel and Interacting Health Emergencies.
    Nieuwlaat R; Mbuagbaw L; Mertz D; Burrows LL; Bowdish DME; Moja L; Wright GD; Schünemann HJ
    Clin Infect Dis; 2021 May; 72(9):1657-1659. PubMed ID: 32544232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial Resistance in Agri-Food Chain and Companion Animals as a Re-emerging Menace in Post-COVID Epoch: Low-and Middle-Income Countries Perspective and Mitigation Strategies.
    Bandyopadhyay S; Samanta I
    Front Vet Sci; 2020; 7():620. PubMed ID: 33195500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobials in COVID-19: strategies for treating a COVID-19 pandemic.
    Shukla AK; Misra S
    J Basic Clin Physiol Pharmacol; 2023 Jul; 34(4):429-444. PubMed ID: 35503307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital.
    Sinto R; Lie KC; Setiati S; Suwarto S; Nelwan EJ; Djumaryo DH; Karyanti MR; Prayitno A; Sumariyono S; Moore CE; Hamers RL; Day NPJ; Limmathurotsakul D
    Antimicrob Resist Infect Control; 2022 May; 11(1):73. PubMed ID: 35590391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The state of current research on COVID-19 and antibiotic use: global implications for antimicrobial resistance.
    Zyoud SH
    J Health Popul Nutr; 2023 May; 42(1):42. PubMed ID: 37173756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empiric Antibiotics in COVID 19: A Narrative Review.
    Lingas EC
    Cureus; 2022 Jun; 14(6):e25596. PubMed ID: 35795519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the Impact of COVID-19 on Antimicrobial Stewardship Activities/Programs in the United Kingdom.
    Ashiru-Oredope D; Kerr F; Hughes S; Urch J; Lanzman M; Yau T; Cockburn A; Patel R; Sheikh A; Gormley C; Chavda A; Vaghela T; Phillips C; Reid N; Brady A
    Antibiotics (Basel); 2021 Jan; 10(2):. PubMed ID: 33498716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Systematic Review of Antimicrobial Resistance During the COVID-19 Pandemic.
    Burnside JSW; Buchthal OV; Patil U
    Hawaii J Health Soc Welf; 2023 Aug; 82(8):188-193. PubMed ID: 37559691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health systems appraisal of the response to antimicrobial resistance in low- and middle-income countries in relation to COVID-19: Application of the WHO building blocks.
    Patel J; Fernandes G; Mwamelo AJ; Sridhar D
    Glob Policy; 2023 Nov; 14(5):790-796. PubMed ID: 38504997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An insights into emerging trends to control the threats of antimicrobial resistance (AMR): an address to public health risks.
    Asghar A; Khalid A; Baqar Z; Hussain N; Saleem MZ; Sairash ; Rizwan K
    Arch Microbiol; 2024 Jan; 206(2):72. PubMed ID: 38252323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 Pandemic-to-Endemic Transition in Indonesia: What Does the Future Hold?
    Sinto R
    Acta Med Indones; 2022 Apr; 54(2):159-160. PubMed ID: 35818655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New threatening of SARS-CoV-2 coinfection and strategies to fight the current pandemic.
    Goel N; Ahmad R; Fatima H; Khare SK
    Med Drug Discov; 2021 Jun; 10():100089. PubMed ID: 33748740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How COVID-19 Has Influenced Public Interest in Antimicrobials, Antimicrobial Resistance and Related Preventive Measures: A Google Trends Analysis of Italian Data.
    Maugeri A; Barchitta M; Basile G; Agodi A
    Antibiotics (Basel); 2022 Mar; 11(3):. PubMed ID: 35326842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance.
    Malik SS; Mundra S
    Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the COVID-19 pandemic on antimicrobial resistance: a debate.
    van Duin D; Barlow G; Nathwani D
    JAC Antimicrob Resist; 2020 Sep; 2(3):dlaa053. PubMed ID: 34192250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of tsunami of resistance to some antibiotics is not far-fetched which used during COVID-19 pandemic.
    Hosseini M; Ahmed Hamad M; Mohseni G; Salamy S; Dehghan Tarzjani S; Taati Moghadam M
    J Clin Lab Anal; 2023 Aug; 37(15-16):e24959. PubMed ID: 37650531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.
    Chakraborty N; Jha D; Roy I; Kumar P; Gaurav SS; Marimuthu K; Ng OT; Lakshminarayanan R; Verma NK; Gautam HK
    J Nanobiotechnology; 2022 Aug; 20(1):375. PubMed ID: 35953826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.